Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Turhan Caskurlu is active.

Publication


Featured researches published by Turhan Caskurlu.


Urologia Internationalis | 2005

Increased Expression of EZH2, a Polycomb Group Protein, in Bladder Carcinoma

Serdar Arisan; Elif Damla Buyuktuncer; Narcin Palavan-Unsal; Turhan Caskurlu; Omer Onur Çakir; Erbil Ergenekon

Introduction: Recent experiments have demonstrated that polycomb group gene enhancer zeste homolog 2 (EZH2) is highly expressed in many cancer types. Therefore, we aim to demonstrate EZH2 gene expression in transitional cell bladder cancer. Patients and Methods: The reverse transcriptase-polymerase chain reaction (RT-PCR) was used for detection of EZH2 mRNA levels in healthy and cancerous human bladder specimens. Also, expression of the particular protein was determined by Western blotting and immunohistochemistry to confirm RT-PCR results. Results: Gradually increased expression of EZH2 was detected by mRNA and protein levels in highly advanced bladder cancer specimens. In contrast, 100% of control subjects were negative for EZH2 expression. The expression of EZH2 was more frequent in G3 (92%) than G1-G2 (62–63%) and more frequent in T1-2 (72–85%) than Ta (56%). Western blot analysis results confirm the RT-PCR results. Conclusions: EZH2 overexpression precedes high frequencies of proliferation and the gradual advance of bladder cancer. These observations suggest that deregulated expression of EZH2 is associated with bladder carcinoma.


Urology | 2012

Comparison of Retrograde Intrarenal Surgery and Mini-percutaneous Nephrolithotomy in Children With Moderate-size Kidney Stones: Results of Multi-institutional Analysis

Berkan Resorlu; Ali Unsal; Abdulkadir Tepeler; Gokhan Atis; Zafer Tokatli; Derya Öztuna; Abdullah Armagan; Cenk Gurbuz; Turhan Caskurlu; Remzi Saglam

OBJECTIVE To compare the outcomes of miniaturized percutaneous nephrolithotomy (mini-perc) and retrograde intrarenal surgery (RIRS) in children for 10- to 30-mm renal calculi by evaluating operative data, stone-free rates, and associated complications. METHODS The records of 201 pediatric patients who underwent mini-perc (n = 106) or RIRS (n = 95) for intrarenal stones of 10- to 30-mm size were reviewed retrospectively. The χ(2) test was applied to compare the success rates, postoperative complications, and blood transfusion rates, and the Mann-Whitney U test was used to compare the means of hospital stay, fluoroscopy, and operative time for mini-perc and RIRS. RESULTS The stone-free rate was 84.2% for the RIRS group and 85.8% for the mini-perc group after a single procedure (P = .745). These percentages increased to 92.6% and 94.3% with adjunctive therapies for RIRS and mini-perc, respectively. Minor complications classified as Clavien I or II occurred in 17% and 8.4% in mini-perc and RIRS, respectively. No major complications (Clavien III-V) occurred in either group. Overall complication rates in mini-perc were higher, but the differences were not statistically significant (P = .07). However, 7 patients in the mini-perc group received blood transfusions, whereas none of the children in the RIRS group were transfused (P = .015). The mean hospital stay, fluoroscopy, and operation times were significantly longer in the mini-perc group. CONCLUSION This study demonstrates that RIRS is an effective alternative to mini-perc in pediatric patients with intermediate-sized renal stones. Operative time, radiation exposure, hospital stay, and morbidities of percutaneous nephrolithotomy (PNL) can be significantly reduced with the RIRS technique.


PLOS ONE | 2014

miR-1 and miR-133b Are Differentially Expressed in Patients with Recurrent Prostate Cancer

Omer Faruk Karatas; Esra Guzel; Ilknur Suer; Isin Dogan Ekici; Turhan Caskurlu; Chad J. Creighton; Michael Ittmann; Mustafa Ozen

Prostate cancer (PCa) is currently the most frequently diagnosed malignancy in the western countries. It is more prevalent in older men with 75% of the incident cases above 65 years old. After radical prostatectomy, approximately 30% of men develop clinical recurrence with elevated serum prostate-specific antigen levels. Therefore, it is important to unravel the molecular mechanisms underlying PCa progression to develop novel diagnostic/therapeutic approaches. In this study, it is aimed to compare the microRNA (miRNA) profile of recurrent and non-recurrent prostate tumor tissues to explore the possible involvement of miRNAs in PCa progression. Total RNA from 41 recurrent and 41 non-recurrent PCa tissue samples were used to investigate the miRNA signature in PCa specimens. First of all, 20 recurrent and 20 non-recurrent PCa samples were profiled using miRNA microarray chips. Of the differentially expressed miRNAs, miR-1, miR-133b and miR-145* were selected for further validation with qRT-PCR in a different set of 21 recurrent and 21 non-recurrent PCa samples. Data were statistically analyzed using two-sided Students t-test, Pearson Correlation test, Receiver operating characteristic analysis. Our results demonstrated that miR-1 and mir-133b have been significantly downregulated in recurrent PCa specimens in comparison to non-recurrent PCa samples and have sufficient power to distinguish recurrent specimens from non-recurrent ones on their own. Here, we report that the relative expression of miR-1 and mir-133b have been significantly reduced in recurrent PCa specimens in comparison to non-recurrent PCa samples, which can serve as novel biomarkers for prediction of PCa progression.


International Journal of Urology | 2005

Urodynamic findings in children with cerebral palsy

M. Ihsan Karaman; Cevdet Kaya; Turhan Caskurlu; Soner Güney; Erbil Ergenekon

Abstract


Journal of Pediatric Surgery | 2013

Initial report of microperc in the treatment of pediatric nephrolithiasis

Mesrur Selcuk Silay; Abdulkadir Tepeler; Gokhan Atis; Ahmet Ali Sancaktutar; Mesut Piskin; Cenk Gurbuz; Necmettin Penbegül; Ahmet Ozturk; Turhan Caskurlu; Abdullah Armagan

BACKGROUND/PURPOSE To report the first technical feasibility and safety of microperc in the treatment of pediatric nephrolithiasis. METHODS A multicenter prospective trial was initiated and microperc was performed in 19 children from four different centers. In all cases, 4.85-Fr all-seeing needle was used to access the collecting system under direct vision. Stone fragmentation was performed using a 200-μm holmium: YAG laser fiber either through the same needle sheath or an 8-Fr microsheath. Patient- and procedure-related factors and perioperative and postoperative parameters were analyzed. RESULTS The mean age of the children was 7.5 ± 4.4 years. Mean stone size was 14.8 ± 6.8mm. Conversion to Mini-PNL was required in two patients because of optical default in one and the high stone burden in the other. The mean hospital stay was 1.8 ± 0.8 days and the mean hemoglobin decrease was 0.1 mg/dl. The overall stone-free rate at 1 month was 89.5%. In one patient with obstructed ureteropelvic junction, intravasation of the irrigation fluid has led to abdominal distention and managed with percutaneous drainage intraoperatively. No other postoperative complication was recorded and no ancillary procedure was required. CONCLUSIONS Microperc is a safe and effective procedure in the treatment of pediatric kidney stones.


International Journal of Urology | 2004

The etiology of erectile dysfunction and contributing factors in different age groups in Turkey

Turhan Caskurlu; Ali Ihsan Tasci; Sefa Resim; Tayfun Sahinkanat; Erbil Ergenekon

Abstract  Background:  The aim of the present study was to determine the pathophysiological factors which cause erectile dysfunction (ED), as well as the risk factors in different age groups in Turkey.


The Journal of Sexual Medicine | 2010

Sexual Dysfunction in Women with Clinical Hypothyroidism and Subclinical Hypothyroidism

Gokhan Atis; Ayhan Dalkilinc; Yuksel Altuntas; Alev Atis; Turhan Caskurlu; Erbil Ergenekon

INTRODUCTION Hypothyroidism is a common hormonal disorder in women that may affect the phases of female sexual function. AIM To investigate female sexual function in patients with clinic hypothyroidism and subclinic hypothyroidism. METHODS A total of 25 women with clinic hypothyroidism (group 4), 25 women with subclinic hypothyroidism [thyroid stimulating hormone (TSH) value <or=10 mU/L (group 2), TSH value >10 mU/L (group 3)], and 20 age matched voluntary healthy women controls (group 1) were included in the study. All the subjects were evaluated with a detailed medical and sexual history, including a female sexual function index (FSFI) questionnaire for sexual status and the Beck Depression Inventory for psychiatric assessment. MAIN OUTCOME MEASURES The levels of serum TSH, thyroid hormones, prolactin (PRL), free testosterone, estradiol, follicle-stimulating hormone, luteinizing hormone, lipid profile, and blood glucose were measured. RESULTS Female sexual dysfunction (FSD) was diagnosed in 14 of 25 patients (56%) in group 4, in 6 of 11 patients (54.6%) in group 3, in 2 of 14 patients (14.6%) in group 2, and while only 3 of 20 the control group of women (15%) had FSD (P = 0.006). The mean total FSFI scores were 23.9 in the group 4, 26.03 in the group 3, 29.2 in the group 2, and 32.30 in the control group (P < 0.0001). The mean BDI score for clinic hypothyroidic patients was significantly greater than the scores for the control group and for the group 2 (P = 0.017 and P = 0.043, respectively). The mean PRL levels for patients in group 4 and group 3 were found to be significantly higher than the level for controls (P < 0.0001), whereas other serum hormone levels were not different among groups. CONCLUSIONS A significant percent of women with clinic hypothyroidism and subclinic hypothyroidism with TSH values >10 mU/L had sexual dysfunction. Hyperprolactinemia, hyperlipidemia, and depression were associated with FSD in clinic hypothyroidism. Different than clinic hypothyroidism depression was not associated with FSD in subclinic hypothyroidism with TSH values >10 mU/L.


Urology | 2013

Retrograde Intrarenal Surgery for the Treatment of Renal Stones in Patients With a Solitary Kidney

Gokhan Atis; Cenk Gurbuz; Ozgur Arikan; Mert Kilic; Sabri Pelit; Cengiz Canakci; Samet Gungor; Turhan Caskurlu

OBJECTIVE To evaluate the efficacy and safety of retrograde intrarenal surgery (RIRS) in the treatment of renal stones in patients with a solitary kidney. MATERIALS AND METHODS From December 2008 to March 2012, 24 patients with a solitary kidney who were treated with RIRS for renal stones were included in the study. All patients were preoperatively evaluated with urine culture, serum biochemistry, urinary ultrasonography, noncontrast computed tomography or intravenous urography, or both. The procedure was considered as successful in patients with complete stone disappearance or fragments <4 mm on computed tomography. Preoperative, operative, and postoperative data of the patients were retrospectively analyzed. The mean serum creatinine levels before and after the procedures were compared using a paired sample t-test. RESULTS The study included 24 patients with a mean age of 44.41 ± 12.15 years (range, 24-70). The mean stone size was 19.83 ± 5.90 mm (range, 10-35). The mean operative time was 55.83 ± 10.90 minutes (range, 40-75). The success rates were 83.3% and 95.8% after the first and second procedures, respectively. A pigtail stent was placed in all patients. The mean serum creatinine levels before the procedures and at 2 weeks after removal of the pigtail stents were 1.54 ± 0.55 mg/dL (range, 0.7-2.8) and 1.56 ± 0.50 mg/dL (range, 0.9-2.6), respectively (P = .92). Minor complications, classified as Clavien I or II, occurred in 4 patients (16.6%). No major complications (Clavien III-V) occurred in the study group. CONCLUSION RIRS is an effective and safe procedure that can be used to manage renal stones in patients with a solitary kidney.


Urological Research | 2014

The cost analysis of flexible ureteroscopic lithotripsy in 302 cases

Cenk Gurbuz; Gokhan Atis; Ozgur Arikan; Ozgur Efilioglu; Asif Yildirim; Onur Danacıoglu; Turhan Caskurlu

The objective of this study was to audit the cost of flexible ureterorenoscopic lithotripsy. The data for 302 consecutive flexible ureteroscopic lithotripsy (FURSL) procedure undertaken in our department for renal stone treatment were collected retrospectively. The costs associated with performing FURSL, including the cost of ancillary equipment were analyzed. This includes the cost of the initial purchase of the ureterorenoscopes and the holmium laser equipment. The cost of flexible ureterorenoscopy for each lithotripsy procedure (for a total of 302 FURSL) was


Cancer Investigation | 2015

Overexpression of miR-145-5p inhibits proliferation of prostate cancer cells and reduces SOX2 expression.

Mustafa Ozen; Omer Faruk Karatas; Sukru Gulluoglu; Omer Bayrak; Serhat Sevli; Esra Guzel; Isin Dogan Ekici; Turhan Caskurlu; Mustafa Solak; Chad J. Creighton; Michael Ittmann

118. Additional cost of ancillary equipment including laser device, ureteral acces sheath and stone retrival catheter were

Collaboration


Dive into the Turhan Caskurlu's collaboration.

Top Co-Authors

Avatar

Gokhan Atis

Istanbul Medeniyet University

View shared research outputs
Top Co-Authors

Avatar

Asif Yildirim

Istanbul Medeniyet University

View shared research outputs
Top Co-Authors

Avatar

Cenk Gurbuz

Istanbul Medeniyet University

View shared research outputs
Top Co-Authors

Avatar

Bulent Erol

Zonguldak Karaelmas University

View shared research outputs
Top Co-Authors

Avatar

Cenk Gurbuz

Istanbul Medeniyet University

View shared research outputs
Top Co-Authors

Avatar

Ozgur Arikan

Istanbul Medeniyet University

View shared research outputs
Top Co-Authors

Avatar

Cengiz Canakci

Istanbul Medeniyet University

View shared research outputs
Top Co-Authors

Avatar

Turgay Turan

Istanbul Medeniyet University

View shared research outputs
Top Co-Authors

Avatar

Mert Kilic

Istanbul Medeniyet University

View shared research outputs
Top Co-Authors

Avatar

Ismail Ulus

Istanbul Medeniyet University

View shared research outputs
Researchain Logo
Decentralizing Knowledge